- CEO
- Philippe Kehren
- Full Time Employees
- 9,000
- Sector
- Basic Materials
- Industry
- Chemicals
- Address
- Rue de Ransbeek, 310 Brussels Belgium 1120
- IPO Date
- Aug 3, 2012
- Business
- Solvay SA engages in the production and sale of essential chemicals worldwide, focusing on basic and performance chemicals for resilient markets including consumer goods, healthcare, food, electronics, building and construction, automotive, and resources. The company offers soda ash and derivatives such as sodium bicarbonate and calcium chloride; hydrogen peroxide and peroxides; silica including highly dispersible silica; specialty chemicals; and products from Coatis such as guar derivatives and surfactants, marketed through over 1,000 product lines with safety data sheets in 39 languages. Founded in 1863 and headquartered in Neder-Over-Heembeek, Brussels, Belgium, Solvay operates approximately 45 industrial sites and 12 R&I centers across 41 countries in Europe, North America, Asia, Latin America, and other regions, employing over 9,000 people following its 2023 demerger that created Syensqo for specialty chemicals. Recent developments include signing two supply contracts in November 2025 with U.S. magnet manufacturers Permag and LCM for rare earths like NdPr and DyTb to bolster secure supply chains; a ten-year agreement with Sapio for Europe's first renewable hydrogen production hub by mid-2026; advancement of the For Generations sustainability roadmap targeting carbon neutrality by 2050 with 30% Scope 1 and 2 emissions reduction by 2030; ongoing operational transformation yielding €110 million in cost savings by end-2024 toward a €200 million target; expansion of recycling capacities at sites like Livorno, Italy for circular silica; completion of a share buyback program in October 2024; and strong 2024 financials with €4.7-4.88 billion in revenues and €1.246 billion underlying EBITDA despite market challenges.